GlassScriptPhysician profile
Sharon A Giordani
NPI 1720201965
$1,338.21
in general payments reported to CMS, 2019-2025
19 companies · $522 in 2025
The $522 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.66 · 2023: $322 · 2024: $472 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,315.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $259.25 | 2024-2025 | Otezla, Otezla, Enbrel |
| Ucb, INC. | $180.29 | 2023-2025 | Cimzia, Bimzelx |
| Glaxosmithkline, LLC. | $145.57 | 2023-2025 | Benlysta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $128.73 | 2023-2025 | Xifaxan |
| Novo Nordisk INC | $91.53 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Organon LLC | $80.79 | 2023-2025 | Hadlima, Renflexis |
| Janssen Biotech, INC. | $68.40 | 2024-2025 | Tremfya |
| Abbvie INC. | $52.66 | 2023-2024 | |
| Pfizer INC. | $52.16 | 2023-2025 | |
| Kyowa Kirin, INC. | $50.93 | 2023-2024 | Crysvita |
| Lilly USA, LLC | $37.71 | 2023-2025 | Zepbound, Taltz |
| Currax Pharmaceuticals LLC | $32.38 | 2025 | Contrave |
| Alexion Pharmaceuticals, INC. | $29.39 | 2024 | Strensiq |
| Novartis Pharmaceuticals Corporation | $24.43 | 2023 | |
| Radius Health, INC. | $23.80 | 2023 | Tymlos |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $22.66 | 2021 | |
| Ani Pharmaceuticals, INC. | $19.90 | 2025 | Purified Cortrophin Gel |
| E.R. Squibb & Sons, L.L.C. | $18.95 | 2024 | Orencia |
| Exact Sciences Corporation | $18.68 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Giordani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.